Sionna Therapeutics, Inc. (SION) stock
SIONNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.97−0.10 (-3.26%)
Close on Nov 18, 2026Market cap $134.28MP/E –Yield –
Sionna Therapeutics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Sionna Therapeutics's operating income for the twelve months ending Sep 30, 2026 was -$120.50M. For fiscal 2025 it was -$88.98M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$88.98M | – |
| FY2024 | Dec 31, 2024 | -$70.56M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$34.82M | – |
| Q2 FY2026 | Jun 30, 2026 | -$32.47M | – |
| Q1 FY2026 | Mar 31, 2026 | -$29.60M | – |
| Q4 FY2025 | Dec 31, 2025 | -$23.61M | – |
| Q3 FY2025 | Sep 30, 2025 | -$23.81M | – |
| Q2 FY2025 | Jun 30, 2025 | -$21.91M | – |
| Q1 FY2025 | Mar 31, 2025 | -$19.66M | – |
| Q4 FY2024 | Dec 31, 2024 | -$18.13M | – |
| Q3 FY2024 | Sep 30, 2024 | -$27.98M | – |
| Q2 FY2024 | Jun 30, 2024 | -$11.29M | – |
| Q1 FY2024 | Mar 31, 2024 | -$13.15M | – |
See a number that looks wrong?